Approval · Notice of Compliance 22390 · 2019
DACOGEN: Notice of Compliance 22390
Issued July 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22390
- Date
- July 11, 2019
- Company
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DACOGEN | 02490366 | Approved |
Medicinal ingredients
- DECITABINE 50 MG per VIAL